ZENSUN ENT released its interim results, with a loss attributable to shareholders of 502 million yuan, a year-on-year narrowing of 68.56%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, ZENSUN ENT released its interim results for the six months ending June 30, 2025, with revenue of 2.624 billion yuan (RMB, the same below), an increase of 1326.78% year-on-year; the loss attributable to shareholders was 502 million yuan, a decrease of 68.56% year-on-year; basic loss per share was 26.2 cents
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments